Purple Biotech (PPBT) Current Assets (2014 - 2026)
Purple Biotech (PPBT) reported Current Assets of $6.8 million for Q1 2026, down 9.79% year-over-year from $7.5 million in Q1 2025, and down 31.29% quarter-over-quarter from $9.9 million in Q4 2025.
Purple Biotech (PPBT) Current Assets (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 13 years of Current Assets data on file, last reported at $6.8 million in Q1 2026.
- Current Assets for Q1 2026 came in at $6.8 million, down 9.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.8 million (down 9.79% YoY), and the FY2025 annual result was $9.9 million, up 10.75% from the prior year.
- Current Assets fell to $6.8 million in Q1 2026 per PPBT's latest filing, from $9.9 million in the prior quarter.
- Over five years, Current Assets peaked at $41.9 million in Q1 2022 and troughed at $6.3 million in Q2 2025.
- A 5-year average of $17.6 million and a median of $11.4 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2025: Current Assets sank 59.43% in 2024, then jumped 55.29% in 2025.
- A 5-year view of Current Assets shows it stood at $33.3 million in 2022, then slumped by 52.53% to $15.8 million in 2023, then slumped by 43.58% to $8.9 million in 2024, then gained by 10.75% to $9.9 million in 2025, then sank by 31.29% to $6.8 million in 2026.
- Business Quant data shows PPBT's Current Assets at $6.8 million in Q1 2026, $9.9 million in Q4 2025, and $10.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | 6.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.78 Mn |
| Dec 31, 2025 | 9.87 Mn |
| Sep 30, 2025 | 10.77 Mn |
| Jun 30, 2025 | 6.31 Mn |
| Mar 31, 2025 | 7.52 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Sep 30, 2024 | 6.94 Mn |
| Jun 30, 2024 | 7.86 Mn |
| Mar 31, 2024 | 11.40 Mn |
| Dec 31, 2023 | 15.79 Mn |
| Sep 30, 2023 | 16.72 Mn |
| Jun 30, 2023 | 19.38 Mn |
| Mar 31, 2023 | 24.41 Mn |
| Dec 31, 2022 | 33.26 Mn |
| Sep 30, 2022 | 34.31 Mn |
| Jun 30, 2022 | 37.45 Mn |
| Mar 31, 2022 | 41.90 Mn |
| Dec 31, 2021 | 48.47 Mn |
| Sep 30, 2021 | 47.20 Mn |
| Jun 30, 2021 | 50.00 Mn |